Where to get Wegovy, Mounjaro, or their base ingredients, semaglutide and tirzepatide While the most obvious route to accessing Wegovy or Mounjaro would be to go through your primary care physician or the prescribing medical professional who helps you manage diabetes, overweight, or obesity, there are numerous online platforms that provide more convenient access
Both act on GLP-1 receptors, and combining them greatly increases the risk of severe GI side effects, hypoglycemia (in diabetes patients), and other adverse events, without providing additional clinical benefit
They're also portable, require no preparation, and provide energy before exercise
3 In January 2026, the FDA published the largest review to date, analysing 91 placebo-controlled GLP-1 trials covering 107,910 patients alongside a real-world cohort study of 2.2 million patients
They then applied GLP-1 receptor antagonists and the rate increase disappeared completely
The research team also thought it was important to mention that by week 26 of the experimental period, treatment with semaglutide led to a dose-dependent decrease in mean body weight
